| Literature DB >> 19053760 |
Daniela Andrei1, Anna E Maciag, Harinath Chakrapani, Michael L Citro, Larry K Keefer, Joseph E Saavedra.
Abstract
A number of bis(diazeniumdiolates) that we designed to release up to 4 mol of nitric oxide (NO) and that are structural analogues of the NO prodrug and anticancer lead compound O(2)-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl} 1-(N,N-dimethylamino)diazen-1-ium-1,2- diolate (PABA/NO) were synthesized and studied. A majority of these compounds yielded higher levels of NO, were better inhibitors of proliferation of a number of cancer cell lines, and more rapidly induced substantially increased levels of S-glutathionylation of cellular proteins in comparison with PABA/NO. In most cases, the antiproliferative activity and extents of S-glutathionylation correlated well with levels of intracellular NO release. We report bis(diazeniumdiolates) to be a class of S-glutathionylating agents with potent antiproliferative and S-glutathionylating activity.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19053760 PMCID: PMC2629944 DOI: 10.1021/jm800831y
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446